June 20, 2013
1 min read
Save

Nontypeable H. influenzae main pathogen causing recurrent AOM

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Nontypeable Haemophilus influenzae was the main otopathogen that caused bacteriologic relapses in children with acute otitis media treated with amoxicillin/clavulanate, according to recent study findings in The Pediatric Infectious Disease Journal.

“In our AOM research center and private practice, we don’t consider it ethical to prescribe amoxicillin as first-line therapy for AOM because we have shown that only 30% of the bacteria we isolate from tympanocentesis in initial AOM or [recurrent] AOM are susceptible to amoxicillin,” researchers wrote.

The prospective study included 66 pneumococcal conjugate vaccinated children aged 6 to 36 months who experienced recurrent AOM less than 1 month after completing amoxicillin/clavulanate therapy.

Researchers found that nontypeable H. influenzae (NTHi) accounted for 47% of initial AOMs and Streptococcus pneumoniae accounted for 15% (P<.0001). NTHi caused more recurrent AOMs than S. pneumoniae (42% vs. 24%, respectively).

NTHi that produces beta-lactamase and penicillin nonsusceptible S. pneumoniae was not more common in recurrent AOM than in initial AOM. Of 21 paired NTHi isolates genotyped, 61.9% were the same organism and 11.1% S. pneumoniae isolates were the same (P=.017). However, recurrent AOM that occurred within 1 week of stopping amoxicillin/clavulanate treatment was a different pathogen in 21% of cases, 33% in cases occurring 8 to 14 days later, 441% in cases occurring 15 to 21 days later and 57% in cases occurring 22 to 30 days later.

“Our findings support use of amoxicillin/clavulanate as the first-line antibiotic for AOM in pneumococcal conjugate vaccinated children,” researchers wrote.

Disclosure: The study was funded in part by NIH.